Related Experiment Video
Updated: Aug 5, 2026

High-throughput and Comprehensive Drug Surveillance Using Multisegment Injection-Capillary Electrophoresis-Mass Spectrometry
Published on: April 23, 2019
Improving the Throughput and Specificity for Small-Molecule Analysis During First-Tier Mass Spectrometry-Based
Samantha L Isenberg1, Charles A Pickens1, Rachel Lee1
1Division of Laboratory Sciences, National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA.
New mass spectrometry methods significantly boost newborn screening throughput and specificity. These advancements in flow injection analysis tandem mass spectrometry (FIA-MS/MS) and liquid chromatography tandem mass spectrometry (LC-MS/MS) improve early disease detection.
Area of Science:
- Clinical Chemistry and Mass Spectrometry
- Biomarker Discovery and Analysis
- Newborn Screening Technologies
Background:
- Current newborn screening relies on rapid, less specific first-tier assays, often requiring slower, more specific second-tier tests.
- Stagnant throughput and specificity of first-tier assays limit the ability to screen for an expanding number of disorders.
- Need for higher-throughput and more specific assays in newborn screening laboratories is critical.
Purpose of the Study:
- To develop and evaluate novel first-tier tandem mass spectrometry assays for newborn screening.
- To enhance assay throughput and analytical specificity using a modern LC-MS/MS platform.
- To assess the performance of a rapid flow injection analysis tandem mass spectrometry (FIA-MS/MS) and a hydrophilic interaction chromatography (HILIC) guard column LC-MS/MS assay.
Main Methods:
- Developed and tested two first-tier tandem mass spectrometry methods on a dual-needle, dual-loop LC-MS/MS system.
- Assayed a 30-second FIA-MS/MS method for increased throughput.
- Evaluated a rapid LC-MS/MS method using a HILIC guard column (1TH) for improved specificity, assessing recovery, precision, linearity, and matrix effects.
Main Results:
- The 30-second FIA-MS/MS assay quadrupled the throughput of existing 2-minute assays.
- The 1TH LC-MS/MS method successfully separated critical isobaric and isomeric biomarkers, reducing matrix effects.
- The 1TH LC-MS/MS method demonstrated improved specificity and quantification accuracy while maintaining acceptable analytical performance for newborn screening.
Conclusions:
- Advances in LC-MS/MS instrumentation enable substantial increases in newborn screening throughput or improved analytical specificity.
- First-tier LC-MS/MS with a HILIC guard column enhances specificity, potentially reducing the need for second-tier testing.
- These methods offer flexible solutions for expanding newborn screening panels without compromising quality or efficiency.
More Related Videos
Related Concept Videos
Peptide Identification Using Tandem Mass Spectrometry
This technique helps gather information regarding the protein from which the peptide was obtained and to study the peptides’ amino acid sequence. Identifying peptides from a complex mixture is an important component of the growing field of...
Tandem Mass Spectrometry
Rapid Identification of Pathogens

